Turnstone Biologics Corp. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 08/14/2025 | 3.10 M | $1.11 M | 0.00% | 13.39% |
| FMR LLC | 08/14/2025 | 1.13 M | $407.10 K | 0.00% | 4.90% |
| BML CAPITAL MANAGEMENT, LLC | 08/11/2025 | 1.10 M | $396.12 K | 0.00% | 4.77% |
| TAKEDA PHARMACEUTICAL CO LTD | 08/08/2025 | 895.82 K | $321.60 K | 0.00% | 3.87% |
| POINT72 ASSET MANAGEMENT, L.P. | 08/14/2025 | 816.92 K | $293.28 K | -7.06% | 3.53% |
| 72 INVESTMENT HOLDINGS, LLC | 08/14/2025 | 549.98 K | $197.44 K | 0.00% | 2.38% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/08/2025 | 130.08 K | $46.70 K | -4.90% | 0.56% |
| DELTEC ASSET MANAGEMENT LLC | 07/18/2025 | 106.06 K | $38.07 K | 100.00% | 0.46% |
| VANGUARD GROUP INC | 08/11/2025 | 83.93 K | $30.13 K | -83.71% | 0.36% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2025 | 79.31 K | $28.47 K | 213.40% | 0.34% |
| HRT FINANCIAL LP | 08/14/2025 | 55.86 K | $20.00 K | 362.29% | 0.24% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2025 | 47.10 K | $16.91 K | 17.16% | 0.20% |
| GTS SECURITIES LLC | 08/08/2025 | 45.16 K | $16.21 K | 100.00% | 0.20% |
| XTX TOPCO LTD | 08/12/2025 | 37.79 K | $13.57 K | 5.72% | 0.16% |
| NORTHERN TRUST CORP | 08/13/2025 | 18.41 K | $6.61 K | 0.00% | 0.08% |
| ACADIAN ASSET MANAGEMENT LLC | 08/07/2025 | 16.43 K | $4.00 K | -7.87% | 0.07% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/15/2025 | 4.74 K | $1.70 K | -0.42% | 0.02% |
| BLACKROCK, INC. | 08/12/2025 | 1.07 K | $383 | -97.49% | 0.00% |
| JPMORGAN CHASE & CO | 08/12/2025 | 158 | $57 | -19.39% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2025 | 150 | $54 | -99.98% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 08/14/2025 | 121 | $43 | 0.00% | 0.00% |
| UBS GROUP AG | 08/14/2025 | 71 | $25 | 0.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
| PFM HEALTH SCIENCES, LP | 08/14/2025 | 0 | $0 | -100.00% | 0.00% |
| NORDWAND ADVISORS, LLC | 08/11/2025 | 0 | $0 | -100.00% | 0.00% |
Turnstone Biologics Corp. institutional Ownership - FAQ's
During the previous two years, 23 institutional investors and hedge funds held shares of Turnstone Biologics Corp.. The most heavily invested institutionals were:
UBS Group AG: 0
Point72 Asset Management, L.P.: 0
VANGUARD GROUP INC: 0
TAKEDA PHARMACEUTICAL CO LTD: 0
HRT FINANCIAL LP: 0
72 Investment Holdings, LLC: 0
35.55% of Turnstone Biologics Corp. stock is owned by institutional investors.
Institutional investors have bought a total of 41.34 K shares in the last 24 months. This purchase volume represents approximately $14.88 K in transactions.